Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Optinose Inc (OPTN)
NASDAQ:OPTN
Holding OPTN?
Track your performance easily
OPTN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.82 - $31.50
Previous CloseN/A
Volume6.27K
Average Volume (3M)56.78K
Market Cap
$60.63M
Enterprise Value$161.32M
Total Cash (Recent Filing)$36.80M
Total Debt (Recent Filing)$15.26M
Price to Earnings (P/E)―
Beta1.92
Next Earnings
Mar 06, 2025EPS Estimate
-0.76Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.23
Shares Outstanding10,055,300
10 Day Avg. Volume52,966
30 Day Avg. Volume56,782
Standard Deviation0.23
R-Squared0.00117
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.80
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market Cap2.66
Enterprise Value/Revenue2.13
Enterprise Value/Gross Profit2.59
Enterprise Value/Ebitda-8.39
Forecast
1Y Price Target
$12.00Price Target Upside88.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Optinose News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OPTN FAQ
What was Optinose Inc’s price range in the past 12 months?
Optinose Inc lowest stock price was $4.82 and its highest was $31.50 in the past 12 months.
What is Optinose Inc’s market cap?
Optinose Inc’s market cap is $60.63M.
When is Optinose Inc’s upcoming earnings report date?
Optinose Inc’s upcoming earnings report date is Mar 06, 2025 which is in 46 days.
How were Optinose Inc’s earnings last quarter?
Optinose Inc released its earnings results on Nov 12, 2024. The company reported $0 earnings per share for the quarter, beating the consensus estimate of -$0.788 by $0.788.
Is Optinose Inc overvalued?
According to Wall Street analysts Optinose Inc’s price is currently Undervalued.
Does Optinose Inc pay dividends?
Optinose Inc does not currently pay dividends.
What is Optinose Inc’s EPS estimate?
Optinose Inc’s EPS estimate is -0.76.
How many shares outstanding does Optinose Inc have?
Optinose Inc has 10,055,300 shares outstanding.
What happened to Optinose Inc’s price movement after its last earnings report?
Optinose Inc reported an EPS of $0 in its last earnings report, beating expectations of -$0.788. Following the earnings report the stock price went down -21.875%.
Which hedge fund is a major shareholder of Optinose Inc?
Currently, no hedge funds are holding shares in OPTN
---
Optinose Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (88.09% Upside)
$12.00 (88.09% Upside)
Hedge Fund Trend
Decreased
By 5.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 10.3%
Last 30 Days ▼ 10.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
29.20%
Trailing 12-Months
Company Description
Optinose Inc
OptiNose, Inc. is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
---
OPTN Company Deck
---
OPTN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there are positive trends in prescription growth and revenue per prescription, the overall financial performance did not meet expectations, resulting in a downward revision of revenue guidance. There are also operational challenges in prescription fulfillment and prior authorization requirements.Read More>---
OPTN Stock 12 Month Forecast
Average Price Target
$12.00
▲(88.09% Upside)
Technical Analysis
Omeros
―
Xeris Pharmaceuticals
―
EyePoint Pharmaceuticals
―
TuHURA Biosciences
―
Aurinia Pharmaceuticals
―
Cassava Sciences
―
Best Analysts Covering OPTN
1 Year
1 Year Success Rate
2/18 ratings generated profit
1 Year Average Return
-44.77%
reiterated a buy rating 2 months ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -44.77% per trade.
---